At close: December 13 at 4:00:01 PM EST
After hours: 7:58:23 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-35,065.0000
-31,710.0000
-28,175.0000
-28,946.0000
-29,000.0000
Investing Cash Flow
15,189.0000
59,428.0000
-107,373.0000
--
-32.0000
Financing Cash Flow
9,963.0000
-7,910.0000
111,307.0000
20,775.0000
16,720.0000
End Cash Position
16,052.0000
32,397.0000
12,589.0000
36,830.0000
45,001.0000
Interest Paid Supplemental Data
--
331.0000
594.0000
603.0000
180.0000
Capital Expenditure
-50.0000
-137.0000
-159.0000
--
-32.0000
Issuance of Capital Stock
9,697.0000
1,710.0000
105,410.0000
21,183.0000
3,135.0000
Issuance of Debt
--
--
--
--
14,000.0000
Repayment of Debt
-127.0000
-9,504.0000
-5,833.0000
--
--
Repurchase of Capital Stock
-1,213.0000
--
--
--
--
Free Cash Flow
-35,115.0000
-31,847.0000
-28,334.0000
-28,946.0000
-29,032.0000
12/31/2020 - 5/7/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PALI Palisade Bio, Inc.
1.7700
-25.00%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
PBM Psyence Biomedical Ltd.
1.8500
-9.31%
CRDF Cardiff Oncology, Inc.
3.9200
+19.88%
IPHA Innate Pharma S.A.
3.0200
+96.10%
CMRX Chimerix, Inc.
2.9500
+0.34%
PCSA Processa Pharmaceuticals, Inc.
1.1100
-11.20%
DBVT DBV Technologies S.A.
3.5700
-7.03%
APVO Aptevo Therapeutics Inc.
4.0900
-27.35%
QURE uniQure N.V.
15.40
+2.26%